J. Gibson

发表

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

S. Montoto, Sonali M. Smith, D. Maloney, 2014, Bone Marrow Transplantation.

transplantation for follicular lymphoma Comparison of autologous and allogeneic hematopoietic stem cell

J. Armitage, J. Vose, M. Horowitz, 2013 .

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

J. Vose, Sonali M. Smith, P. Hari, 2012, Blood.

A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03).

H. Prince, D. Zannino, D. Roos, 2019, International journal of radiation oncology, biology, physics.

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

lymphoma: myeloablative or reduced intensity? Conditioning regimens for allotransplants for diffuse large B-cell

Sonali M. Smith, P. Hari, P. Armand, 2012 .

Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia

R. Herrmann, P. Browett, A. Schwarer, 2004 .

Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement

J. Vose, S. Montoto, P. Hari, 2013, British journal of haematology.

T‐cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells

D. Joshua, Ross D. Brown, D. Sze, 2000, British journal of haematology.

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

J. Vose, M. Aljurf, R. Gale, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

A. Krishnan, W. Wood, P. Hari, 2015, Bone Marrow Transplantation.

Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study

J. Szer, D. Roos, A. Wirth, 2005, Bone Marrow Transplantation.

A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.

J. Szer, L. To, A. Roberts, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.

P. Hari, R. Gale, M. Cairo, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.

H. Atkins, P. Hari, A. Dispenzieri, 2010, Clinical lymphoma, myeloma & leukemia.

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

P. Hari, R. Kyle, Shaji K. Kumar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of twin and autologous transplants for multiple myeloma.

R. Fonseca, P. Hari, R. Kyle, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia

R. Herrmann, J. Szer, J. Matthews, 1999, British journal of haematology.

Allogeneic haemopoietic cell transplants in Australia, 1996 – A multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow

J. Szer, L. To, A. Dodds, 2001, Bone Marrow Transplantation.

SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation

S. Pergam, W. Stevenson, I. Kerridge, 2021, Open forum infectious diseases.

Festschrift Maternal autoimmune disease influences self‐tolerance in offspring: The role of suppressor cells and materno‐foetal cell traffic

A. Basten, J. Gibson, 1988, Immunology and cell biology.

J. Vose, P. Hari, R. Gale, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION

A. Krishnan, S. Lonial, P. Hari, 2013, Bone Marrow Transplantation.

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

P. Hari, R. Kyle, D. Reece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Aggressive natural killer cell leukemia/lymphoma

S. Dunkley, J. Gibson, D. Joshua, 1998, Pathology.

Multiple myeloma: Relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes

H. Kronenberg, D. Joshua, Ross D. Brown, 1988, American journal of hematology.

Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter.

J. Szer, J. Cebon, W. Sheridan, 1994, Leukemia.

Older patients with myeloma derive similar benefit from autologous transplantation.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR.

S. Montoto, P. Hari, R. Gale, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?

J. Wagner, M. Perales, H. Lazarus, 2019, Haematologica.

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.

Alan M. Miller, J. Armitage, J. Vose, 2003, Blood.

M. Perales, F. Appelbaum, J. Pidala, 2014, Haematologica.

I. Kerridge, D. Ma, W. Stevenson, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Ruta Bajorunaite, Arturo Molina, John Gibson, 2003, Blood.

Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.

A. Gratwohl, J. Passweg, H. Lazarus, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

Alan M. Miller, J. Vose, Sonali M. Smith, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Salvage second hematopoietic cell transplantation in myeloma.

J. Vose, A. Krishnan, S. Lonial, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age

S. Jagannath, R. Kyle, J. Wingard, 2003, Bone Marrow Transplantation.

Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma

S. Lonial, P. Hari, A. Dispenzieri, 2011, Bone Marrow Transplantation.

Autologous Predeposit Blood Donation in Pregnancy ‐ a Perspective

L. Zipparo, J. Gibson, J. Gibson, 1993, The Australian & New Zealand journal of obstetrics & gynaecology.

Cytokine priming of acute myeloid leukemia may produce a pulmonary syndrome when associated with a rapid increase in peripheral blood myeloblasts.

J. Szer, J. Cebon, W. Sheridan, 1993, Blood.

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

J. Armitage, R. Herzig, A. Bashey, 2001, Bone Marrow Transplantation.

Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma

D. Goldstein, J. Matthews, R. Penny, 1997, British journal of haematology.

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.

D. Heitjan, P. Hari, R. Kyle, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

J. Vose, S. Montoto, Sonali M. Smith, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

IS THE INTERNATIONAL STAGING SYSTEM SUPERIOR TO THE DURIE SALMON STAGING SYSTEM? A COMPARISON IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT

P. Hari, R. Kyle, D. Reece, 2009, Leukemia.

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

R. Herrmann, D. Joske, J. Bashford, 2005, Bone Marrow Transplantation.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, J. Klein, 2015, Biology of Blood and Marrow Transplantation.

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.

H. Goldschmidt, P. Hari, D. Reece, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation

J. Szer, T. Hughes, S. Durrant, 2004, Internal medicine journal.

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Alan M. Miller, J. Armitage, J. Vose, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study

G. Cook, D. Marks, S. Feyler, 2007, Bone Marrow Transplantation.

Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim

S. Durrant, I. Lewis, J. Marty, 2003, Bone Marrow Transplantation.

Cytosine Arabinoside and Etoposide (CARE) in relapsed and refractory non-hodgkin’s Lymphoma

H. Kronenberg, R. Mansberg, J. Gibson, 1992, Medical Oncology and Tumor Pharmacotherapy.

Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

A. Zannettino, C. Tam, S. Harrison, 2022, Internal medicine journal.

Syngeneic stem cell transplantation for HIV‐related lymphoma

H. Iland, D. Joshua, J. Gibson, 1999, British journal of haematology.

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.

J. Armitage, J. Vose, M. Horowitz, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Leukaemias into the 21st century: part 1: the acute leukaemias

D. Joshua, H. Iland, J. Gibson, 2012, Internal medicine journal.

Leukaemias into the 21st century – part 2: the chronic leukaemias

Christina Brown, D. Joshua, H. Iland, 2013, Internal medicine journal.

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

J. Armitage, J. Vose, E. Montserrat, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group

A. Zannettino, J. Szer, A. Roberts, 2015, Internal medicine journal.

Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group

A. Zannettino, J. Szer, A. Roberts, 2015, Internal medicine journal.

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

J. Vose, Sonali M. Smith, P. Hari, 2012, Blood.

Leukaemias into the 21st century: part 1: the acute leukaemias

Christina Brown, D. Joshua, H. Iland, 2012, Internal medicine journal.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, D. Maloney, 2015, Biology of Blood and Marrow Transplantation.

1. WHAT'S NEW IN AUTOIMMUNE HAEMOLYTIC ANAEMIA (1997-2000)

W. Erber, A. McQuillan, D. Grey, 2001 .